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Ana R. Neves,1* Wietske A. Pool,2 Ana Solopova,2 Jan Kok,2 Helena Santos,1 and Oscar P. Kuipers2
Instituto de Tecnologia Química e Biolo´gica, Universidade Nova de Lisboa, Av. da Repu´blica (EAN), 2780-157 Oeiras,
Portugal,1 and Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute,
University of Groningen, P.O. Box 14, 9750 AA Haren, Netherlands2
Received 19 May 2010/Accepted 21 August 2010
Accumulation of galactose in dairy products due to partial lactose fermentation by lactic acid bacteria yields
poor-quality products and precludes their consumption by individuals suffering from galactosemia. This study
aimed at extending our knowledge of galactose metabolism in Lactococcus lactis, with the final goal of tailoring
strains for enhanced galactose consumption. We used directed genetically engineered strains to examine
galactose utilization in strain NZ9000 via the chromosomal Leloir pathway (gal genes) or the plasmid-encoded
tagatose 6-phosphate (Tag6P) pathway (lac genes). Galactokinase (GalK), but not galactose permease (GalP),
is essential for growth on galactose. This finding led to the discovery of an alternative route, comprising a
galactose phosphotransferase system (PTS) and a phosphatase, for galactose dissimilation in NZ9000. Intro-
duction of the Tag6P pathway in a galPMK mutant restored the ability to metabolize galactose but did not
sustain growth on this sugar. The latter strain was used to prove that lacFE, encoding the lactose PTS, is
necessary for galactose metabolism, thus implicating this transporter in galactose uptake. Both PTS trans-
porters have a low affinity for galactose, while GalP displays a high affinity for the sugar. Furthermore, the
GalP/Leloir route supported the highest galactose consumption rate. To further increase this rate, we over-
expressed galPMKT, but this led to a substantial accumulation of -galactose 1-phosphate and -glucose
1-phosphate, pointing to a bottleneck at the level of -phosphoglucomutase. Overexpression of a gene encoding
-phosphoglucomutase alone or in combination with gal genes yielded strains with galactose consumption
rates enhanced up to 50% relative to that of NZ9000. Approaches to further improve galactose metabolism are
discussed.
Lactococcus lactis is a lactic acid bacterium widely used in
the dairy industry for the production of fermented milk prod-
ucts. Because of its economic importance, L. lactis has been
studied extensively in the last 40 years. A small genome, a large
set of genetic tools, a wealth of physiological knowledge, and a
relatively simple metabolic potential render L. lactis an attrac-
tive model with which to implement metabolic engineering
strategies (reviewed in references 21 and 57).
In the process of milk fermentation by L. lactis, lactose is
taken up and concomitantly phosphorylated at the galactose
moiety (C-6) by the lactose-specific phosphoenolpyruvate
(PEP)-dependent phosphotransferase system (PTSLac), after
which it is hydrolyzed to glucose and galactose 6-phosphate
(Gal6P) (64). The glucose moiety enters the glycolytic pathway
upon phosphorylation via glucokinase to glucose 6-phosphate
(G6P), whereas Gal6P is metabolized to triose phosphates via
the D-tagatose 6-phosphate (Tag6P) pathway, encompassing the
steps catalyzed by galactose 6-phosphate isomerase (LacAB),
Tag6P kinase (LacC), and tagatose 1,6-bisphosphate aldolase
(LacD) (Fig. 1). Curiously, during the metabolism of lactose by
L. lactis, part of the Gal6P is dephosphorylated and excreted
into the growth medium, while the glucose moiety is readily
used (2, 7, 51, 56, 60).
As a result of incomplete lactose utilization, some fermented
dairy products contain significant residual amounts of galac-
tose. The presence of galactose has been associated with shod-
dier qualities of the fermented product (6, 27, 43). In particu-
lar, galactose is a major contributor to the browning that
occurs when dairy products (e.g., yogurt and mozzarella, Swiss,
and cheddar cheese) are cooked or heated in the manufacture
of pizzas, sauce preparation, or processed cheese. In addition,
availability of residual galactose may result in production of
CO2 by heterofermentative starters and, consequently, in tex-
tural defects such as the development of slits and fractures in
cheeses. Therefore, the availability of starter strains with im-
proved galactose utilization capacity is desirable to develop
higher-quality dairy products. Additionally, strains with in-
creased galactose metabolism could provide galactose-free
foods for individuals and, in particular, children suffering from
the rare disease galactosemia (36). To this end, a comprehen-
sive understanding of galactose catabolism is essential.
Galactose metabolism in L. lactis was thoroughly studied in
the past and has been and still is the subject of some contro-
versy. Indeed, conflicting results regarding the type of PTS
involved in galactose uptake have been published. Some au-
thors advocated that galactose is exclusively transported via the
plasmid-encoded PTSLac, whereas others proposed transport
via a galactose-specific PTS (PTSGal) to the extreme of ques-
tioning the contribution of the PTSLac (17, 20, 50, 59). How-
ever, a gene encoding PTSGal has never been identified in L.
lactis. Independently of the nature of the PTS, it is generally
accepted that the resulting Gal6P is metabolized via the Tag6P
pathway (lac operon) (Fig. 1). On the other hand, galactose
translocated via the highly specific galactose permease (GalP)
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is metabolized via the Leloir pathway to -glucose 1-phosphate
(-G1P) through the sequential action of galactose mutarotase
(GalM), galactokinase (GalK), and galactose 1-phosphate uri-
dylyltransferase (GalT)/UDP-galactose-4-epimerase (GalE)
(gal operon). Entry in glycolysis is preceded by the -phospho-
glucomutase (-PGM)-catalyzed isomerization of -G1P to
G6P. The use of the Leloir and/or the Tag6P pathway for
galactose utilization is currently viewed as being strain depen-
dent (9, 16, 25, 32, 33, 58), but the relative efficacy in the
degradation of the sugar has not been established.
The ultimate aim of this study was to engineer L. lactis for
improved galactose-fermenting capacity as a means to mini-
mize the galactose content in dairy products. To gain insight
into galactose catabolism via the Leloir (gal genes) and the
Tag6P (lac genes) pathways, a series of L. lactis subsp. cremoris
NZ9000 isogenic gal and lac mutants were constructed. Carbon
13 labeling experiments coupled with nuclear magnetic reso-
nance (NMR) spectroscopy were used to investigate galactose
metabolism in the gal and lac strains. The data obtained re-
vealed a novel route for galactose dissimilation and provided
clues to further enhance galactose utilization.
MATERIALS AND METHODS
Microbial strains used and growth conditions. The strains and plasmids used
in this study are listed in Table 1. For genetic manipulation, strains were rou-
tinely grown at 30°C in M17 broth (Difco, Sparks, MD) containing 0.5% (wt/vol)
glucose. For physiological characterization, cultures were grown in chemically
defined medium (CDM) (52) with 1% (wt/vol) galactose under anaerobic con-
ditions in rubber-stoppered bottles (200 ml) or in a 2-liter fermentor (Biostat
MD; B. Braun Biotech International, Melsungen, Germany) and at a tempera-
ture of 30°C. When appropriate, erythromycin or chloramphenicol was used at 5
g ml1. Expression of genes cloned downstream of the nisin-inducible PnisA
promoter was induced when the optical density at 600 nm (OD600) was between
0.25 and 0.5 by addition of a supernatant (0.01%, vol/vol) of an overnight culture
of the nisin producer L. lactis NZ9700 (29) or by addition of a nisin solution (1
g liter1 in a 50% [vol/vol] ethanol solution). In the fermentor, the medium was
gassed with argon for 60 min prior to inoculation (4% inoculum from a culture
grown overnight). The pH was kept at 6.5 by automated addition of 10 M NaOH,
and an agitation rate of 70 rpm was used to keep the system homogeneous.
Growth was monitored by measuring the OD600. Specific growth rates () were
calculated through linear regressions of the plots of ln(OD600) versus time during
the exponential growth phase.
General DNA manipulations. General DNA techniques were performed es-
sentially as described before (55). Plasmid DNA was isolated by the method of
Birnboim and Doly (8). Restriction enzymes, T4 DNA ligase, Expand polymer-
ase, and Taq DNA polymerase were obtained from Roche Diagnostics GmbH
(Mannheim, Germany) and were used according to the supplier’s instructions.
PCR amplifications were performed in an Eppendorf thermal cycler (Eppendorf,
Hamburg, Germany) with L. lactis MG1363 chromosomal DNA as the template,
unless described otherwise, using appropriate conditions. The primers used in
this study are described in Table 2.
Construction of overexpression vectors. Cloning of genes involved in the
Leloir pathway was performed as follows: the PCR products obtained with
primer pairs GalA1-fw/GalA-rev and GalA1-fw/GalT-rev were cloned as
1.39-kb and 6.60-kb Eco31I/XbaI restriction fragments in NcoI/XbaI-re-
stricted pNG8048e, resulting in plasmids pGalP (galP cloned downstream of the
nisin-inducible promoter PnisA) and pGalPMKT (galPMKT downstream of
PnisA), respectively. The plasmids were introduced by electrotransformation (26)
into L. lactis NZ9000.
To clone the pgmA gene (1.72 kb) of Streptococcus thermophilus ST11, primers
were designed on the sequence of S. thermophilus LY03 (accession number
IMDST01, culture collection at VU, Brussels, Belgium). The PCR products
obtained with primer pair PgmA-fw1/PgmA-rev or PgmA-fw2/PgmA-rev were
cloned as NcoI/XbaI or XbaI restriction fragments in NcoI/XbaI-restricted
pNZ8048 to obtain pPgmA and in XbaI-restricted pGalP and pGalPMKT to
obtain pGalPpgmA and pGalPMKTpgmA, respectively. Variants of the plasmids
that carried pgmA downstream and in the same orientation as the gal gene(s)
were selected in L. lactis NZ9000. Plasmid constructs were checked by EcoRI
restriction enzyme analysis.
The Tag6P pathway genes lacFE, lacABCD, and lacABCDFE were amplified
by PCR using pMG820 DNA as the template and primer pairs LacFE-fw/LacFE-
rev, LacAD-fw/LacAD-rev, and LacAE-fw/LacAE-rev (Table 2). The overex-
pression plasmids pLacFE, pLacABCD, and pLacABCDFE were constructed by
cloning the 2.04-kb RcaI/XbaI, 2.89-kb PtsI/SpeI, and 4.95-kb SphI/SpeI restric-
tion fragments into NcoI/XbaI-, PtsI/SpeI-, and SphI/SpeI-restricted pNZ8048,
respectively. lacG was amplified using primer pair LacG-fw and LacG-rev, re-
stricted with SacI, and cloned into SacI-restricted pLacABCDFE. The lacG
orientation in pLacABCDFEG was confirmed by restriction enzyme analysis.
The resulting constructs were transformed (26) into L. lactis NZ9000galPMK.
Construction of galP- and galPMK-deletion strains. The PCR products ob-
tained with primer pairs GalA-KO1/GalA-KO2 and GalA-KO3/GalA-KO4 were
cloned together as XbaI/BamHI and BamHI/EcoRI restriction fragments in
XbaI/EcoRI-restricted pORI280 (35), resulting in pORI280-galP. This plasmid
FIG. 1. Schematic overview of the alternative routes for galactose
uptake and further catabolism in L. lactis. Galactose can be imported
by the non-PTS permease GalP and metabolized via the Leloir path-
way (galMKTE) to -G1P, which is converted to the glycolytic inter-
mediate G6P by -phosphoglucomutase (pgmH). Alternatively, galac-
tose can be imported by PTSLac (lacFE) and further metabolized to
triose phosphates by the Tag6P pathway (lacABCD). Here, we propose
a new uptake route consisting of galactose translocation via the galac-
tose PTS, followed by dephosphorylation of the internalized Gal6P to
galactose, which is further metabolized via the Leloir pathway
(highlighted in the gray box). galP, galactose permease; galM, ga-
lactose mutarotase; galK, galactokinase; galT, galactose 1-phos-
phate uridylyltransferase; galE, UDP-galactose-4-epimerase; pgmH,
-phosphoglucomutase; lacAB, galactose 6-phosphate isomerase; lacC,
Tag6P kinase; lacD, tagatose 1,6-bisphosphate aldolase; lacFE, PTSLac;
PTSGal, unidentified galactose PTS; Phosphatase; unidentified Gal6P-
phosphatase; pgi, phosphoglucose isomerase; pfk, 6-phosphofructo-1-ki-
nase; fba, fructose 1,6-bisphosphate aldolase; tpi, triose phosphate isomer-
ase; -Gal1P, -galactose 1-phosphate; -G1P, -glucose 1-phosphate;
UDP-gal, UDP-galactose; UDP-glc, UDP-glucose; G6P, glucose 6-phos-
phate; Gal6P, galactose 6-phosphate; Tag6P, tagatose 6-phosphate; TBP,
tagatose 1,6-bisphosphate; FBP, fructose 1,6-bisphosphate; DHAP, dihy-
droxyacetone phosphate; GAP, glyceraldehyde 3-phosphate. The dotted
arrow represents the conversions of GAP to pyruvate via the glycolytic
pathway. Steps essential to improve galactose consumption are shown in
black boxes.
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was obtained using L. lactis LL302 (34) as the cloning host. PCR products
obtained with primer pairs GalA-KO1/GalA-KO2 and GalAMK-KO5/GalAMK-
KO6 were cloned as XbaI/BamHI and BamHI/EcoRI restriction fragments in
XbaI/EcoRI-restricted pORI280, resulting in pORI280-galPMK, which was ob-
tained and maintained in L. lactis LL302. Introducing pORI280-galP or
pORI280-galPMK together with helper plasmid pVE6007 in L. lactis NZ9000,
followed by a two-step homologous recombination event (35), yielded strains
NZ9000galP and NZ9000galPMK, respectively. The chromosomal structures
of both strains were confirmed by PCR analysis and Southern blotting using
enhanced chemiluminescence (ECL) detection (Amersham Pharmacia Biotech)
with a PCR fragment obtained with primer pair GalA-KO1/GalA-KO2 as the
probe.
Enzyme assays. For enzymatic assays, cells were disrupted using 0.5 g glass
beads (diameter, 50 to 105 m; Fischer Scientific BV, Den Bosch, Netherlands)
and a Mini-BeadBeater-8 apparatus (Biospec Products, Inc., Bartlesville, OK)
with two 1-min pulses separated by 1 min of cooling down on ice. Cell debris was
pelleted, and activities were assayed at 30°C. Protein concentrations were deter-
mined by the method of Bradford (11).
(i) -Phosphoglucomutase. Cell cultures grown to an OD600 of 0.25 were
treated with nisin (0.01% [vol/vol] supernatant of NZ9700), as described above.
When the cultures reached an OD600 of 1 (approximately 4 h after induction),
the cells were centrifuged (2,500  g, 7 min), washed twice with potassium
phosphate (KPi) buffer (10 mM, pH 7.2), and resuspended in the same buffer.
-PGM specific activity in cell extracts was assayed as described by Qian et al.
(54). The 1-ml assay mixture contained 50 mM triethanolamine-HCl (TEA; pH
7.2), 5 mM MgCl2, 0.5 mM NADP, 50 M glucose-1,6-bisphosphate, and 1.75
U glucose-6-phosphate dehydrogenase. Reactions were started by the addition
of 1.5 mM -G1P. One unit of enzyme is defined as the amount of enzyme
TABLE 1. Lactococcal strains and plasmids used in this study
Strain or plasmid Description Referenceor source
L. lactis strains
MG1363 L. lactis subsp. cremoris, plasmid-free derivative of NCDO712 24
NZ9000 MG1363 pepN::nisRK 31
NZ9700 Nisin-producing transconjugant with the nisin-sucrose transposon Tn5276 29
LL302 MG1363 RepA carrying a single copy of pWV01 repA in pepX 34
NZ9000galP NZ9000 with deletion of galP This work
NZ9000galPMK NZ9000 with deletion of galPMK This work
S. thermophilus ST11 Gal-negative strain 44
Plasmids
pNZ8048 Cmr, nisin-inducible PnisA 19
pNG8048e Cmr Emr PnisA, pNZ8048 derivative containing erythromycin resistance gene Lab coll.
a
pORI280 Emr LacZ RepA ori 35
pVE6007 Cmr ori(Ts), derivative of pWV01 42
pMG820 23.7-kb derivative of pLP712 containing lacFEGABCD 41
pGalP pNG8048e with galP cloned in the NcoI/XbaI site, Cmr This work
pGalPMKT pNG8048e with galPMKT cloned in the NcoI/XbaI site, Cmr This work
pPgmA pNZ8048 with pgmA of S. thermophilus cloned in the NcoI/XbaI site This work
pGalPpgmA pGalP with pgmA of S. thermophilus cloned in the XbaI site This work
pGalPMKTpgmA pGalPMKT with pgmA of S. thermophilus cloned in the XbaI site This work
pLacFE pNZ8048 with lactococcal pMG820 lacFE cloned in the RcaI/XbaI site This work
pLacABCD pNZ8048 with lactococcal pMG820 lacABCD cloned in the PtsI/SpeI site This work
pLacABCDFE pNZ8048 with lactococcal pMG820 lacABCDFE cloned in the SpeI/SpeI site This work
pLacABCDFEG pLacABCDFE with lactococcal pMG820 lacG cloned in the SacI site This work
a Lab coll., laboratory collection.
TABLE 2. Primers used in this study
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catalyzing the conversion of 1 mol of substrate (NADP) per min assayed
at 340 nm.
Activities involved in galactose catabolism in L. lactis strain NZ9000galP.
Cells were grown in galactose (0.5%, wt/vol)-CDM, harvested in the mid-expo-
nential phase of growth, centrifuged (2,500  g, 7 min), washed twice with TEA
buffer (50 mM, pH 7.2), and resuspended in the same buffer, after which cell
extracts were prepared. All the reaction mixtures contained 50 mM TEA buffer,
pH 7.2, 5 mM MgCl2, and cell extract (about 2 mg total protein) in a final volume
of 0.55 ml. The reactions were initiated by the addition of 5 mM sugar substrate
(Gal6P, Gal1P, or galactose). After 1 h of incubation at 30°C, 50 l of 2H2O was
added and the reaction products were analyzed by 31P NMR spectroscopy.
Alternatively, the reactions were monitored online, and 31P spectra were ac-
quired every 2.5 min. ATP and the phosphatase inhibitor sodium fluoride were
added to the reaction mixtures to final concentrations of 2.5 mM and 10 mM,
respectively. -Glucose 1,6-bisphosphate (50 M) was added when appropriate.
31P NMR spectra were recorded using a selective probe head (31P-SEX)
at 30°C on an Avance II 500-MHz spectrometer (Bruker BioSpin GmbH,
Karlsruhe, Germany) by using standard Bruker pulse programs. Spectra were
referenced to the resonance of external 85% H3PO4, designated 0 ppm.
Galactose PTS assay. L. lactis strain NZ9000galP was grown to an optical
density at 600 nm of 2.2 in galactose-CDM, and PTS activity was determined as
described by LeBlanc et al. (32). Briefly, 20 ml of late-exponential-phase cells was
harvested, washed twice with KPi buffer (100 mM, pH 7.2), and suspended in 5
ml of the same buffer supplemented with MgCl2 (5 mM). The cells in this
suspension were permeabilized with 250 l of toluene-acetone (1:9), and 50 l of
permeabilized cells was used in the assays. The 1-ml assay mixture contained 100
mM KPi (pH 7.2), 5 mM MgCl2, 15 mM NADH, 10 U lactate dehydrogenase, 10
mM NaF, and 20 mM galactose. Reactions were started by the addition of 5 mM
PEP. The oxidation of NADH was measured in a PEP-dependent manner.
In vivoNMR spectroscopy. Carbon-13 spectra were acquired at 125.77 MHz on
an Avance II 500-MHz spectrometer (Bruker BioSpin GmbH). All in vivo ex-
periments were run using a quadruple nucleus probe head at 30°C, as described
before (46). Cells were harvested in the mid-logarithmic phase of growth, washed
twice with 5 mM KPi buffer (pH 6.5), and resuspended in 50 mM KPi (pH 6.5)
to a protein concentration of approximately 15 mg protein ml1. In vivo NMR
experiments were performed using the online system described earlier, which
consists of a minibioreactor coupled to NMR detection with a circulating system
that allows noninvasive studies of metabolism under controlled conditions of pH,
gas atmosphere, and temperature (46). Galactose specifically labeled with 13C on
carbon 1 (20 mM) was added to the cell suspension at time zero. The time
courses of galactose consumption, product formation, and changes in the pools
of intracellular metabolites were monitored in vivo. When the substrate was
exhausted and no changes in the resonances of intracellular metabolites were
observed, an NMR sample extract was prepared as described previously (46, 48).
The lactate in the NMR sample extract was quantified by 1H NMR in an
AMX300 spectrometer (Bruker BioSpin GmbH). The concentrations of the
other metabolites were determined in fully relaxed 13C spectra of the NMR
sample extracts as described previously (48). Due to the fast pulsing conditions
used for acquiring in vivo 13C spectra, correction factors were determined to
convert peak intensities into concentrations (45, 46). The quantitative kinetic
data for intracellular metabolites were calculated as described elsewhere (47,
48). The lower limit for in vivo NMR detection of intracellular metabolites under
these conditions was 3 to 4 mM. Intracellular metabolite concentrations were
calculated using a value of 2.9 l (mg of protein)1 for the intracellular volume
of L. lactis (53). Although the results of individual experiments are illustrated in
each figure, each experiment was repeated at least twice and the results were
highly reproducible. The values reported are averages of two experiments, and
the accuracy varied from 2% (extracellular products) to 10% in the case of
intracellular metabolites with concentrations below 5 mM and varied from 5%
to 10% for the maximal galactose consumption rate.
Analysis of [1-13C]galactose fermentation products by 1H NMR. L. lactis
NZ9000galPMK and derivatives carrying pMG820 or each of the lac constructs
were grown in M17 broth with 1% glucose and an initial pH of 6.5. When
appropriate, chloramphenicol (5 g ml1) was added. Nisin (Sigma, St. Louis,
MO) at a concentration of 1 g l1 was added when the OD600 of the cultures
reached approximately 0.4. After 2 h of induction, cells were harvested, washed
twice (50 mM KPi, pH 6.5), resuspended at a concentration of approximately 5
mg protein ml1 in KPi buffer (50 mM, pH 6.5), and placed in tubes with a
rubber stopper. Argon was bubbled through the suspension for 10 min to ensure
anaerobiosis. [1-13C]galactose (20 mM) was added, and the supernatant was
recovered following 1 h of incubation at 30°C with mild agitation to keep the
system homogeneous. The 13C-labeling pattern of the end products formed from
13C-enriched galactose was determined by 1H NMR analysis. 1H NMR spectra
were acquired in a Bruker AMX300 spectrometer using a 5-mm inverse detec-
tion probe head, 32,000 data points, a 90° flip angle, and a repetition delay of
42.7 s. The water resonance was suppressed with a presaturation pulse.
Transcriptome analysis. The levels of transcripts in NZ9000galP grown on
galactose were compared by transcriptome analysis using full-genome amplicon-
based L. lactis MG1363 DNA microarrays, and the levels of mRNA in
NZ9000galP grown on glucose or the levels of mRNA in NZ9000 grown on
galactose were determined as described elsewhere (30). Cells were grown in
CDM in rubber-stoppered bottles as described above and harvested at an OD600
of 0.25. The experiments were performed essentially as described elsewhere (62)
with the modifications introduced previously (51).
Chemicals. [1-13C]galactose (99% enrichment) was obtained from Euriso-top
(Gif-Sur-Yvette, France). Formic acid (sodium salt) was purchased from Merck
Sharp & Dohme (Whitehouse Station, NJ). Nisin was obtained from Sigma-
Aldrich (St. Louis, MO). All other chemicals were reagent grade.
RESULTS
L. lactis NZ9000 can import galactose via more than one
transport system. L. lactis can use the Leloir pathway, the
Tag6P pathway, or both pathways for galactose metabolism in
a strain-dependent manner (58). Presumably, L. lactis subsp.
cremoris NZ9000 (MG1363pepN::nisRK) internalizes galactose
by a secondary carrier symporter (GalP) and further metabo-
lizes the sugar exclusively via the Leloir pathway (25), as this
strain lacks the plasmid-linked genes encoding the Tag6P path-
way. To assess the potential of the Tag6P route for galactose
catabolism, a strategy was devised that consisted of introduc-
tion of plasmid pMG820 (41) with genes lacABCDFEG, en-
coding the lactose PTS (lacFE), the Tag6P pathway enzymes
(lacABCD), and a 	-phosphogalactosidase (lacG) (64), in mu-
tants in which galactose utilization via the Leloir pathway was
prevented. Grossiord et al. (25) previously reported blockage
of the Leloir pathway by inactivation of the galactose per-
mease gene. In our study, galP was deleted in strain NZ9000
using a double-crossover recombination method. The extent
of the deletion is shown in Fig. 2A. Unexpectedly, L. lactis
NZ9000galP was still able to grow in a medium with galactose
as the sole carbon source (Fig. 2B); growth was biphasic and
FIG. 2. Lactococcal strains used in this study and their respective
growth profiles on galactose. (A) Schematic overview of the gal operon
and the genetic makeup of the galP and galPMK deletions in strain
NZ9000. Hooked arrow, putative promoter; lollipop, putative termi-
nator structure; white empty areas, deleted sequence. (B) Growth of L.
lactis NZ9000 and derivatives in CDM supplemented with 55 mM
galactose at 30°C in rubber-stoppered bottles without pH control (ini-
tial pH 6.5). The growth rate () for each strain is also shown.
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characterized by an initial growth rate that was 2.3-fold lower
than a second growth rate, which was similar to that of parent
strain NZ9000 (0.38  0.01 h1). To exclude the possibility of
residual GalP activity due to partial deletion only (Fig. 2A), a
new out-of-frame deletion was made in which only the first
four amino acids of the original protein were left. The behavior
of the resulting strain was in all aspects similar to that of our
original galP-deletion strain. Subsequently, a mutant strain of
L. lactis NZ9000 was made in which, apart from galP, the
downstream genes of the operon, galM (galactose mutarotase)
and galK (galactose kinase), were also deleted (Fig. 2A). De-
letion of galPMK resulted in total loss of the capacity to grow
in a medium with galactose as the sole source of carbon (Fig.
2B). These data imply that L. lactis NZ9000 has an additional
transport system with specificity for galactose.
L. lactis NZ9000 can catabolize galactose via the Tag6P
pathway. Introduction of pMG820 in L. lactis NZ9000galPMK
rendered a strain that could grow in CDM containing lactose (or
glucose, both at 1% [wt/vol]) but not when galactose (1%
wt/vol) was the sole carbon source (data not shown). However,
resting cells of lactose-grown cultures were able to convert
[1-13C]galactose (20 mM) to a mixture of fermentation end prod-
ucts, including [3-13C]lactate, [2-13C]acetate, and [2-13C]ethanol,
as determined by 1H NMR spectroscopy (Fig. 3). To determine
which of the genes within the lac operon were essential for
galactose metabolism, the following combinations of genes
were cloned into pNZ8048 under the control of the nisin pro-
moter: lacABCD, lacFE, lacABCDFE, and lacABCDFEG. The
various constructs were introduced into L. lactis NZ9000-
galPMK. Expression of the lac genes in the different con-
structs was confirmed by SDS-PAGE of cell extracts obtained
from nisin-induced (1 g liter1) glucose-grown cultures (data
not shown). Also, strain NZ9000galPMK(pLacABCDFEG) was
able to grow on lactose (1%, wt/vol)-CDM when the inducer
nisin (1 g liter1) was added at time 0 h (inoculation). Strain
NZ9000galPMK(pLacABCDFE) showed moderate growth
under the same conditions (Table 3), thus showing functional
expression of the lac genes. Like NZ9000galPMK(pMG820),
none of the resulting strains was able to grow in CDM with
galactose (1%, wt/vol) as the carbon source, even though nisin
was added at time 0 h. To determine the galactose-fermenting
capacity of NZ9000galPMK and derivatives harboring the
lac constructs, resting cell suspensions were incubated with
[1-13C]galactose (20 mM), and the end products in the superna-
FIG. 3. 1H NMR spectra of end products formed from the metabolism of [1-13C]galactose (20 mM) by cell suspensions of NZ9000galPMK
and derivatives carrying different lac operon constructs (pLacFE, pLacABCD, pLacABCDFE) or pMG820 at an initial pH of 6.5 and under
anaerobic conditions. Cell suspensions were prepared as described in Materials and Methods. Expression of the lac genes under the control of PnisA
was induced by the addition of 1 g liter1 nisin. 1H NMR spectra were acquired after a 10-fold dilution in 2H2O in a Bruker AMX300
spectrometer with a 5-mm inverse detection probe head and processed with 0.1-Hz line broadening. Isotopomers of lactate, acetate, and ethanol
are indicated. The end-product profile of NZ9000(pLacABCDFEG) was identical to that of NZ9000(pLacABCDFE) and was omitted for the sake
of simplicity. pLacFE, PTSLac; pLacABCD, Tag6P pathway; pLacABCDFE, PTSLac and Tag6P pathway.
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tants were examined by 1H NMR (Fig. 3). Strains NZ9000-
galPMK(pLacABCD) and NZ9000galPMK(pLacFE) and the
negative control, NZ9000galPMK, were unable to metabolize
galactose, as indicated by the absence of labeled end products
in the supernatants. Lactate labeled on carbon 3 was detected
in the supernatants of NZ9000galPMK(pLacABCDFE) and
NZ9000galPMK(pLacABCDFEG), showing that, under the
conditions tested (glucose-grown cells), both the Tag6P en-
zymes (lacABCD) and PTSLac (lacFE) are required for galac-
tose consumption in L. lactis NZ9000galPMK.
Consumption rate and glycolytic dynamics depend on the
route for galactose utilization. The metabolism of [1-13C]galac-
tose (20 mM) in resting cells of strains NZ9000 and NZ9000galP
grown on galactose and strain NZ9000galPMK(pMG820) grown
on lactose was studied by in vivo 13C NMR (Fig. 4). The kinetics
of galactose consumption in NZ9000 was characterized by an
initial lag phase followed by quasilinear galactose consumption
with a maximal rate of 0.16  0.01 mol min1 (mg of pro-
tein)1 (Fig. 4A). During the quasilinear consumption period,
-Gal1P and -G1P, the phosphorylated intermediates of the
Leloir pathway, accumulated to maximal concentrations of
TABLE 3. Maximal OD600s obtained for L. lactis NZ9000galPMK
derivatives during growth on CDM with lactosea








a Lactose was present at 0.5% (wt/vol). The OD600 was evaluated every 12 h
for a period of 48 h. Precultures were grown in CDM with glucose (1%, wt/vol).
FIG. 4. Metabolism of galactose in suspensions of nongrowing cells of L. lactis NZ9000 and its derivatives. Kinetics of [1-13C]galactose (20 mM)
consumption and end-product formation (A, C, and E) as well as pools of intracellular metabolites (B, D, and F) in resting cells of L. lactis strains
NZ9000 (A and B), NZ9000galPMK(pMG820) (C and D), and NZ9000galPMK (E and F) under anaerobic conditions at 30°C with the pH
controlled at 6.5, as monitored by in vivo 13C NMR. Maximal galactose consumption rates (mol min1 mg protein1) are boxed in the upper-left
corners (A, C, and E). Symbols: closed diamond, galactose; gray square, lactate; open triangle, acetate; closed circle, 2,3-butanediol; closed triangle,
fructose 1,6-bisphosphate; open circle, -glucose 1-phosphate; gray diamond, -galactose 1-phosphate; open diamond; 3-phosphoglycerate; open
square, phosphoenolpyruvate; closed square, galactose 6-phosphate; gray inverted triangle, tagatose 1,6-bisphosphate.
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16.7  0.6 and 18.7  0.7 mM, respectively (Fig. 4B). Buildup
of fructose 1,6-bisphosphate (FBP; maximal concentration,
23.0  1.5 mM), the predominant metabolite during glucose
metabolism, was slightly delayed. At the onset of galactose
depletion, 3-phosphoglycerate (3-PGA) and PEP pools build
up to 28.8  2.6 and 11.8  2.3 mM, respectively. Curiously,
the Tag6P pathway intermediate Gal6P accumulated (maximal
concentration, 5.0  0.3 mM) immediately after galactose ad-
dition, decreasing to undetectable levels upon galactose ex-
haustion.
Strain NZ9000galPMK(pMG820) presumably assimilates
galactose via the plasmid-encoded PTSLac and Tag6P pathway
activities. In this strain, the kinetics of galactose consumption
was biphasic: quasilinear consumption with a maximal rate of
0.06  0.01 mol min1 (mg of protein)1 was followed by a
second phase at a rate approximately 3-fold lower (Fig. 4C). A
similar profile for substrate consumption had previously been
observed in an L. lactis strain having cellobiose-specific PTS
(PTSCel) as the single glucose transporter (13), and it resulted
from a strong preference for the 	-glucose anomer. In con-
trast, the second phase of galactose consumption is not asso-
ciated with PTSLac anomeric specificity, as the ratio between -
and 	-galactose utilization rates remains constant throughout
the experiment (data not shown). Therefore, in strain
NZ9000galPMK(pMG820), the slowdown in galactose con-
sumption 17 min after its addition (galactose concentration,

4.5 mM) is probably a consequence of a low affinity for
galactose transport via PTSLac, which is in agreement with
previously reported Km values in the mM range (32). Using a
mathematical model with Michaelis-Menten formalism (13), a
Km value of approximately 8.4 mM was estimated for galactose
uptake in NZ9000galPMK(pMG820). The same model pre-
dicted a Km of galactose uptake by strain NZ9000 of approxi-
mately 0.4 mM, a value close to that reported for galactose
uptake via a permease (Km, 0.13 mM) (59). Accumulation of
the Tag6P pathway intermediate tagatose 1,6-bisphoshate
(maximal concentration, about 10 mM) occurred within sec-
onds after addition of galactose (Fig. 4D), but Gal6P was not
detected in vivo by 13C NMR. In the spectra acquired during
the metabolism of [1-13C]galactose, a resonance due to FBP
labeled in C-6 (, 65.1 ppm) appeared soon after (about 1.5
min) the C-1 peak of tagatose 1,6-bisphoshate (, 66.4 ppm)
became detectable. Tagatose 1,6-bisphoshate labeled in C-6 (,
63.4 ppm) was not detected. The observed labeling pattern is
consistent with scrambling of the 13C label at the level of triose
phosphates and backflux through aldolase (46). Indeed, the
FBP pool showed a profile identical to that of tagatose 1,6-
bisphoshate, but the maximal concentration was somewhat
lower (6.5  1.1 mM). Accumulation of 3-PGA, a metabolite
generally associated with substrate starvation, occurred while
galactose was still abundant; likewise, PEP was also detected
before galactose exhaustion.
The profile of galactose consumption in strain NZ9000galP
resembled that in NZ9000galPMK(pMG820), as it also dis-
played biphasic kinetics, but the rate of the first phase was
nearly 2-fold higher [0.11  0.01 mol min1 (mg of pro-
tein)1] and that of the second phase was considerably shorter
(Fig. 4E). The observed behavior (biphasic kinetics) strongly
indicates the presence of a transporter with a low affinity for
galactose in this strain. The estimated Km value for galactose
uptake is about 6.3 mM. Inactivation of galP apparently caused
no loss of expression of the downstream genes galMKTE in the
gal operon (galPMKTE), as accumulation of -Gal1P and
-G1P during the metabolism of galactose denoted functional
GalKTE enzyme activities (Fig. 4F). Indeed, a whole-genome
transcription analysis revealed no significant differences in the
expression levels of galMKTE genes in NZ9000galP and
NZ9000 cells grown on galactose. In contrast, in the galP mu-
tant the expression levels of galMKT and galE were about
50-fold and 8-fold higher, respectively, during growth on ga-
lactose compared to growth on glucose. FBP was detected only
about 2.5 min after galactose addition, reached a steady con-
centration of 15.9  1.5 mM during the rapid phase, and
decreased to undetectable levels before galactose depletion.
As was the case in NZ9000, Gal6P accumulated immediately
(concentration, about 4 mM) after galactose addition, decreas-
ing to undetectable levels, however, during the transition from
the first to the second phase of galactose consumption. Con-
comitantly, 3-PGA and PEP pools rose to 38.1  2.8 and
11.0  2.2 mM, respectively.
Initial steps for galactose utilization in strain NZ9000galP.
The in vivo 13C NMR data obtained during the metabolism of
galactose in strain NZ9000galP showed accumulation of
-Gal1P, which originates from the ATP-dependent phosphor-
ylation of galactose by GalK. However, mining of the L. lactis
MG1363 genome revealed no clear candidate gene for a ga-
lactose permease alternative to galP. Additionally, detection of
Gal6P immediately after the addition of galactose to cell sus-
pensions of NZ9000galP (and also NZ9000) is indicative of a
galactose PTS activity. Indeed, galactose translocation by a
PTS other than the PTSLac has previously been suggested in L.
lactis (50, 59). Therefore, we hypothesized that transport of
galactose in strain NZ9000galP is mediated via a PTS, leading
to Gal6P, which is subsequently (in)directly converted to
-Gal1P and further metabolized via the Leloir pathway. Spe-
cific galactose PTS activity was assayed using permeabilized
cells of galactose-grown NZ9000 galP: a value of 50  2 nmol
min1 (mg of protein)1 was determined. The step(s) involved
in the conversion of Gal6P to -Gal1P was investigated by
incubating cell-free NZ9000galP extracts with appropriate
phosphorylated substrates coupled to 31P NMR analysis. A
considerable (2-fold) decrease in the resonance due to Gal6P
(, 4.25 ppm) accompanied by an increase in Pi (, 2.28 ppm)
was observed upon incubation of Gal6P with cell extract (Fig.
5A). When the reaction was performed in the presence of the
phosphatase inhibitor NaF, no changes in the Gal6P and Pi
resonances were detected. The data show that Gal6P phos-
phatase activity is present in L. lactis. Direct conversion of
Gal6P into -Gal1P was not observed, ruling out the presence
of a phosphogalactomutase activity. The paucity of phospho-
hexomutase genes in the genome sequence of L. lactis MG1363
(65) and the lack of specificity for phosphogalactose by the
lactococcal -phosphoglucomutase (45) further support the
absence of such a phosphogalactomutase activity.
A resonance due to -Gal1P (, 2.55 ppm) was readily de-
tected upon addition of ATP (2.5 mM) to a reaction mixture in
which dephosphorylation of Gal6P by the cell extract had
occurred (Fig. 5B). The results show that conversion of
Gal6P to -Gal1P entails sequential dephosphorylation and
phosphorylation steps, which are catalyzed by a yet uniden-
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tified phosphatase and GalK, respectively. The requirement
for a functional galactokinase is clear from the inability of
strain NZ9000galPMK to metabolize galactose (Fig. 3). At
this point, it should be noted that the inability of strain
NZ9000galPMK(pLacABCD) to metabolize galactose is not
in contradiction to the presence of an alternative galactose
PTS in the genome. Rather, this result implies that expression
of such a transporter needs to be induced by galactose. In
agreement, suspensions of glucose-grown NZ9000galPMK
cells incubated with [1-13C]galactose failed to accumulate
[1-13C]Gal6P (data not shown), as opposed to NZ9000 and
NZ9000galP cells grown on galactose (Fig. 4). Also in line
with this view is the observed growth behavior of strain
NZ9000galP in galactose-CDM (Fig. 2), with the initial low
growth rate suggesting the need to express new activities for
full growth on galactose.
Searching for alternative galactose PTS in L. lactis using tran-
scriptomics. Our data strongly indicate that strain NZ9000galP
transports galactose via an unknown PTS transporter(s) dis-
playing low affinity for the sugar. Previously, a transcriptome
analysis approach proved useful to identify PTSCel as an addi-
tional glucose transporter in L. lactis (51). Assuming that the
galactose PTS would be expressed at a higher level in the galP
mutant when it was grown on galactose, using full-genome
L. lactis DNA microarrays, we compared the mRNA levels
of galactose-grown NZ9000galP cells with those of glucose-
grown NZ9000galP or galactose-grown NZ9000. Genes encod-
ing PTS proteins and their respective expression levels under
the conditions studied are shown in Table 4. On galactose-
grown cells, loss of GalP did not significantly alter the expres-
sion of genes encoding PTS components, the exception being
llmg_pseudo_54. L. lactis MG1363 llmg_pseudo_54, yidB in
strain IL1403, is annotated as a putative cellobiose-specific
PTS IIC component (10). Curiously, when galactose- and glu-
cose-grown NZ9000galP cells are compared, llmg_pseudo_54
showed the second-highest fold overexpression, after ptcA.
However, the frameshift mutation in llmg_pseudo_54 (nucle-
otide 422 is missing) was confirmed by (re)sequencing llmg_
pseudo_54 from strains MG1363, NZ9000, and NZ9000galP
(grown on glucose or galactose), and thus, this gene fragment
does not seem to produce a functional protein in either strain.
Identification of the galactose PTS is hindered by the number of
PTS-encoding genes (55% of the total) upregulated in galactose-
grown NZ9000galP compared to the number in glucose-grown
cells.
Engineering strategies to improve the capacity for galactose
utilization. From our results on the characterization of the
galactose dissimilation routes, engineering the Leloir pathway
appeared to be the most promising strategy to increase galac-
tose consumption in L. lactis NZ9000 since (i) the strain pos-
sessing the GalP/Leloir pathway showed the highest rate of
galactose utilization and (ii) the PTSLac and the galactose PTS
in L. lactis NZ9000galP display an apparent low affinity for
galactose. Furthermore, improving the capacity to use galac-
tose is likely to require increased -PGM activity, as this en-
zyme was shown to be a metabolic bottleneck in galactose
metabolism (45). Because the native -PGM, an enzyme es-
sential for growth, may be tied to unknown physiological con-
trol elements in L. lactis, we chose to bypass it by engineering
the expression of S. thermophilus pgmA, together with the lac-
tococcal gal operon genes galPMKT.
The genes galPMKT were cloned in pNZ8048, downstream
of the nisin-inducible promoter, and the resulting vector,
pGalPMKT, was introduced into L. lactis NZ9000. The S. ther-
mophilus pgmA was cloned downstream of galT in pGalPMKT.
Nisin-inducible expression of the Leloir genes (galPMKT)
FIG. 5. 31P NMR spectra showing galactose 6-phosphate processing in cell extracts of strain NZ9000galP. The reaction mixtures contained
50 mM TEA buffer, pH 7.2, 5 mM MgCl2, and cell extract (about 2 mg total protein). (A) Traces a and b represent spectra of the reaction mixture
before and after addition of Gal6P (5 mM), respectively. Traces c and d represent spectra of the reaction mixture after 60 min incubation at 30°C
in the absence and in the presence of the phosphatase inhibitor NaF (10 mM), respectively. (B) Conversion of Gal6P in cell extracts of
NZ9000galP monitored online at 30°C by 31P NMR. Traces a and b represent spectra acquired 1.5 and 80 min after addition of Gal6P,
respectively. ATP (2.5 mM) was added to the reaction mixture at time 81 min. Trace c represents a spectrum acquired at time 86 min, 5 min after
addition of ATP. The shifts in Pi and Gal6P resonances are due to pH variation during the assay (online monitoring without pH control). The
resonance labeled x is due to an unidentified compound.
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alone or together with pgmA in NZ9000 was examined by
SDS-PAGE. Bands due to GalP (50.5 kDa) and GalK (43.7
kDa), but not GalM (37.6 kDa) or GalT (56.3 kDa), were
detected in NZ9000(pGalPMKT). Besides GalP and GalK, an
additional band due to -PGM was readily detected in the
crude extracts of NZ9000(pGalPMKTpgmA) (data not shown).
In addition, a 3-fold increased -PGM activity was present in the
crude extracts of induced NZ9000(pGalPMKTpgmA) compared
to that observed in NZ9000(pNZ8048) (Table 5), demonstrating
the functional overexpression of pgmA.
To examine the effect of overproducing the genes in the gal
operon alone or in combination with -PGM, in vivo NMR
coupled to 13C labeling was used to follow the metabolism of
galactose in suspensions of nongrowing cells (Fig. 6). All
strains were grown in CDM containing galactose and were
induced with nisin (0.01% [vol/vol] supernatant of NZ9700) at
an OD600 of 0.5.
Nisin-induced expression of galPMKT did not improve ga-
lactose consumption in strain NZ9000 (compare Fig. 6A with
6C). Instead, it caused increases of about 5 and 15 mM in the
maximal concentrations of the Leloir pathway intermediates
-Gal1P and -G1P, respectively. These data are in line with
the fact that wild-type -PGM activity is insufficient to support
a high flux via the Leloir pathway (45). Indeed, coexpression of
pgmA together with the gal operon genes reduced the -Gal1P
and -G1P pools by approximately 3-fold and led to a 38%
increase in the galactose consumption rate (Fig. 6B). Previ-
ously, a 6-fold increase in the native -PGM activity resulted in
a 25% greater galactose consumption rate (45). As expected,
nisin-induced expression of the streptococcal pgmA per se also
had a positive effect on the galactose consumption rate (an
increase of about 19% when the -PGM activity was 3.8 times
higher; Table 5). Altogether these results prompted a pull-and-
push strategy that consisted of cloning the first gene needed for
galactose utilization, the galactose permease, and pgmA, the
gateway to glycolysis, with the obvious advantage being that
only two genes needed to be cloned. Under the conditions
studied, the resulting strain, NZ9000(pGalPpgmA), presented
the highest galactose consumption rate, which was increased
50% compared to that for control strain NZ9000(pNZ8048).
Furthermore, -Gal1P and -G1P levels were even lower than
those in strain NZ9000(pGalPMKTpgmA) (compare Fig. 6B
with 6D). Curiously, increasing the galactose consumption rate
led to an FBP profile more similar to that observed during the
TABLE 4. Transcription of PTS genes in galactose-grown NZ9000galP compared to that in parent strain NZ9000
or glucose-grown NZ9000galP
Gene Familya Product Substrate (reference)
Up- or downregulationc
galP vs
NZ9000 Gal vs Glc
llmg_0022 (mtlA) Fru IIBC Mannitol (23) 1.23 1.06
llmg_0024 (mtlF) Fru IIA 1.01 1.03
llmg_0187 (celB) Lac IIC Cellobiose/lactose (28) 1.00 1.09
llmg_0437 (ptcB) Lac IIB Cellobiose/glucose (13) 1.14 1.28
llmg_0438 (ptcA) Lac IIA 1.12 5.06
llmg_0440 (ptcC) Lac IIC 1.02 1.32d
llmg_0453 (yedE) Glc IIA Trehalose (4) 1.19 2.17
llmg_0454 (yedF) Glc IIBC 1.15 2.76
llmg_0727 (ptnD) Man IID Mannose/glucose (13) 1.19 2.92
llmg_0728 (ptnC) Man IIC 1.10 2.03
llmg_0729 (ptnAB) Man IIAB 1.10 2.11
llmg_0865 Fru IIA NDb 1.28 1.25
llmg_0866 Gat IIB 1.03 2.33
llmg_0867 Asc IIC 1.07 1.02
llmg_0963 Lac IIC ND 1.14 1.01
llmg_1045 (ptbA) Glc IIABC Salicin (28) 1.23 1.33
llmg_1244 Lac IIC ND 1.16 1.21
llmg_1426 (yleD) Glc IIABC Sucrose (39, 65) 1.20 1.67
llmg_1568 (fruA) Glc IIABC Fructose (5) 1.08 3.51
llmg_pseudo54 (yidB) Lac IIC ND 1.31d 4.16
a PTS families according to the transport classification database (www.tcdb.org): Fru, fructose-mannitol family; Lac, lactose-N,N-diacetylchitobiose-	-glucoside
family; Glc, glucose-glucoside family; Man, mannose-fructose-sorbose family; Gat, galactitol family; Asc, ascorbate family.
b ND, not determined.
c Positive values indicate upregulation, and negative values indicate downregulation. Genes with both significantly altered expression (P 
 0.001) and an expression
ratio of 1.6 are shown in boldface.
d Significantly altered expression.
TABLE 5. -Phosphoglucomutase activity in L. lactis cells grown to













a Galactose was present at 1% (wt/vol). Induction was performed by adding a
supernatant (0.01%, vol/vol) of a full-grown culture of the nisin producer L. lactis
NZ9700 when an OD600 of 0.25 was reached.
b Relative to that in the empty vector pNZ8048 control strain. The results are
averages of two independent cultivations, and the error is below 10%.
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metabolism of glucose (45). Our data show that to improve
galactose utilization in L. lactis subsp. cremoris, at least -PGM
and galactose uptake activities must be above the wild-type
levels.
DISCUSSION
In the 1970s and early 1980s, the efforts of several labora-
tories to elucidate galactose metabolism in L. lactis led to the
publication of conflicting results regarding the uptake step and
the relative contributions/efficiencies of the Leloir and Tag6P
pathways. In this work, we used directed genetically engi-
neered strains to examine galactose utilization via the chromo-
somal Leloir pathway or the plasmid-encoded Tag6P pathway
in L. lactis subsp. cremoris NZ9000. This strain lacks a lac-
tose plasmid (Tag6P pathway) but possesses the gal operon
(galPMKTE), which encodes a galactose permease (galP) and the
enzymes of the Leloir pathway. Assessment of Tag6P pathway
activity in strain NZ9000 requires inactivation of the Leloir
route. To this end, galP- and galPMK-deletion strains were
constructed, but growth on galactose was abolished only when
a gal operon fragment covering galP, galM, and galK was re-
moved. Thus, GalM and/or GalK is crucial for growth of strain
NZ9000 on galactose, whereas GalP is not. GalM is not
present in all bacteria known to metabolize galactose via the
Leloir pathway (1), most likely because the anomerization re-
action catalyzed by the mutarotase (	-Gal7 -Gal) can occur
spontaneously in solution. On the other hand, loss of GalK
abolished galactose fermentation in L. lactis MG1363 (25) and
severely impaired growth of the phylogenetically related or-
ganisms Streptococcus mutans and Streptococcus salivarius (1,
14), denoting the key role of the kinase in organisms relying on
the Leloir pathway for galactose utilization. In fact, a low level
of expression of galK and, thus, insufficient galactokinase ac-
tivity could explain the inability of a previously described lac-
tococcal galP-disruption mutant (MG1363 galP::ery) to grow on
galactose (25). Interestingly, this galP-disruption mutant dis-
played galactose uptake activity (25), which corroborates the
occurrence of an additional transporter(s) with specificity for
galactose in L. lactis MG1363 and derivatives.
Detection of galactose phosphorylated at position C-6 (Gal6P)
both in the galP mutant and in NZ9000 by in vivo NMR
strongly indicated galactose PTS activity, since the formation
of Gal6P is usually associated with translocation of galactose or
lactose via PTS transporters in bacteria. To the best of our
knowledge, production of Gal6P through galactokinase phos-
phorylation on C-6 or a phosphogalactomutase activity (inter-
conversion of -Gal1P and Gal6P) has never been reported. In
agreement, we failed to detect either activity in cell extracts of
strain NZ9000galP by 31P NMR analysis. Galactose PTS ac-
tivity was, however, readily measured in permeabilized cells of
galactose-grown NZ9000galP. Thus, strain NZ9000 possesses
a PTS for galactose uptake, in addition to the secondary carrier
GalP (Fig. 1). The presence of a galactose PTS in strains ML3
and C2, which, like strain NZ9000, derive from the dairy strain
L. lactis NCDO712, has been suggested (50, 59). In an attempt
to identify the additional galactose PTS, we used a transcrip-
tomics approach and compared mRNA levels of galactose-
grown and glucose-grown NZ9000galP. In L. lactis MG1363,
FIG. 6. Galactose consumption and time courses for -Gal1P, -G1P, and FBP pools in resting cells of L. lactis strains engineered to improve
galactose utilization. [1-13C]galactose (20 mM) was supplied at time 0 min to nongrowing suspensions of strains NZ9000(pGalPMKT) (A),
NZ9000(pGalPMKTpgmA) (B), control strain NZ9000(pNZ8048) (C), and NZ9000(pGalPpgmA) (D); and its metabolism was monitored by in
vivo 13C NMR under anaerobic conditions at pH 6.5 and 30°C. Maximal galactose consumption rates (mol min1 mg protein1) are boxed in the
upper-left corners. Symbols: closed diamond, galactose; closed triangle, fructose 1,6-bisphosphate; open circle, -glucose 1-phosphate; gray
diamond, -galactose 1-phosphate.
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12 operons (20 open reading frames) potentially encode PTS-
type transporters (65). Of these, genes in seven operons
showed significant increases in their expression levels during
growth on galactose compared to the levels during growth on
glucose. Upregulation of genes encoding the mannose/glucose
PTS, fructose PTS, and putative trehalose PTS domains is
more likely related to relief of glucose-mediated catabolite
repression than to induction by galactose (5, 13, 66). In fact,
genes encoding the putative trehalose PTS (llmg_0453 and
llmg_0454) showed significantly altered expression levels in an
L. lactis ccpA mutant (40, 66). Transcriptional regulation of the
lactococcal fru operon (encoding the fructose PTS and a
1-phosphofructokinase) by CcpA has been reported (5), and
disruption of the fructose PTS affected only the growth of L.
lactis on fructose; thus, a role of the transporter on galactose
metabolism is unlikely. The mannose/glucose PTS is charac-
terized by a broad substrate specificity being able to transport
mannose, glucose, fructose, N-acetylglucosamine, and 2-deoxy-
glucose (15, 22, 37), but not galactose (15). Unexpectedly, loss
of GalP did not induce significantly altered expression of genes
encoding PTS components, except for a modest, but signifi-
cant, increase in the level of llmg_pseudo_54 (Table 4). This
gene, which encodes a protein with homology to enzymes IIC
of the PTS lactose-N,N-diacetylchitobiose-	-glucoside family
in L. lactis strains IL1403 and SK11, was the second most
upregulated in galactose-grown cells; ptcA, which encodes a
IIACel domain involved in transport processes by two distinct
Lac-family EII integral membrane domains, PtcC and CelB
(13, 28), showed the highest expression increase. In view of
these results, llmg_pseudo_54 and ptcA appeared to be prom-
ising candidates for the galactose PTS domains IIC and IIA. As
such, ptcB emerged as the most likely IIB domain to complete
the sugar-specific PTS complex. However, the frameshift mu-
tation in MG1363 llmg_pseudo_54 was confirmed in strains
NZ9000 and NZ9000galP by sequencing. Consequently, the
identity of the gene encoding the galactose PTS remains elu-
sive. Considering our expression data, firm identification of the
transporter in question most likely requires inactivation in the
galP mutant of each PTS encoded in the genome, a task be-
yond the scope of this work.
In the absence of the Tag6P pathway, metabolism of Gal6P,
the galactose PTS product, requires phosphatase or phospho-
hexomutase activities. In this work, evidence for a dephosphor-
ylation step is presented (Fig. 1), since incubation of
NZ9000galP cell extracts with Gal6P resulted in accumula-
tion of phosphate at the expense of Gal6P. Complete inhibi-
tion of Gal6P hydrolysis by a phosphatase inhibitor (sodium
fluoride) further supports this hypothesis. The occurrence in L.
lactis of phosphatases with specificity for Gal6P has been re-
ported (61), and excretion of galactose to the medium during
growth of L. lactis on lactose is usually rationalized as resulting
from dephosphorylation of Gal6P (7, 51). The genome se-
quence of L. lactis MG1363 possesses at least 18 genes whose
products potentially exhibit phosphatase activity (65). Among
those, 11 genes showed differential expression, but only 5
(llmg_0264, llmg_1288, llmg_1517, llmg_1854, and llmg_2075)
were upregulated when NZ9000galP cells grown on galactose
were compared with NZ9000galP cells grown on glucose.
Specific functions have been attributed only to llmg_0264 (fbp),
which encodes the lactococcal fructose 1,6-bisphosphatase
(38). The gene llmg_1288 (hisK) is not a strong candidate,
since it encodes a histidinol phosphatase (HisK), and all of its
neighboring genes (9 in total), also involved in histidine me-
tabolism, are upregulated (data not shown). llmg_2075 is an-
notated as an ADP-ribose pyrophosphatase, while llmg_1157 is
annotated as a membrane-associated putative phosphatidic
acid phosphatase but shares 98% homology with a histidine
protein kinase-like kinase (49). llmg_1854 is annotated as an
alkaline phosphatase. These enzymes are characterized by a
wide substrate specificity and alkaline pH optimum (pH 8 to
10). Among the genes determined to be upregulated,
llmg_1854 emerges as the best candidate for encoding a phos-
phatase with Gal6P activity. However, if this is the case, the
enzyme is most likely unspecific, as typical of alkaline phos-
phatases. In fact, a lactococcal phosphatase that exhibited af-
finity for several hexose 6-phosphates, including Gal6P, has
been partially purified, but this enzyme showed a pH optimum
of 6.0, and its activity decreased sharply above pH 6.5 (61). The
presence of several unspecific phosphatases catalyzing the hy-
drolysis of Gal6P cannot be ruled out. Most likely, identifica-
tion of the phosphatase(s) involved requires its purification,
which is a task outside the scope of the present study.
An L. lactis NZ9000 strain devoid of Leloir pathway activity
(NZ9000galPMK) can metabolize galactose via the Tag6P
pathway upon introduction of the lactose plasmid pMG820
(Fig. 4), but the sugar does not sustain growth. It seems un-
likely that this feature is related to a low level of expression of
the metabolic genes in NZ9000galPMK(pMG820), since the
lac operon inducer, Tag6P, is formed during metabolism of
galactose via this route (63) and the strain can grow on lactose
(Table 3). Likewise, L. lactis subsp. cremoris FD1 actively me-
tabolizes galactose but does not grow on the sugar (7). This
behavior was explained by a nil fructose 1,6-bisphosphatase
activity, impeding the use of galactose as a gluconeogenic sugar
and, consequently, the production of phosphorylated precur-
sors (G6P and fructose 6-phosphate) for biosynthesis purposes.
The activity of fructose 1,6-bisphosphatase in L. lactis
MG1363-related strains is very low (
15 U) (38, 47) and
might be insufficient to sustain growth of the Tag6P-dependent
strain on galactose. This hypothesis is further supported by the
elevated expression of fructose 1,6-bisphosphatase during
growth on galactose (data not shown). Previously, low fructose
1,6-bisphosphatase activity was shown to be limiting for growth
of L. lactis on fructose (38), a substrate that also requires
gluconeogenic conversion of FBP for biosynthetic purposes
(generation of fructose 6-phosphate and G6P).
The pattern of galactose degradation in strain NZ9000gal-
PMK(pMG820) revived the question as to whether the PTSLac is
able to take up galactose (16, 17, 18, 20, 32, 50, 59, 60). Introduc-
tion of plasmids carrying different combinations of the lac genes
in NZ9000galPMK showed the necessity of lacFE for utilization
of galactose (Fig. 3), indicating uptake of the sugar via PTSLac.
Internalization of galactose in L. lactis NZ9000 occurs via a
secondary carrier (GalP) or a phosphotransfer-driven group
translocator (galactose PTS). Our data show that GalP is a
high-affinity uptake system (Km in the M range), whereas the
galactose PTS is a low-affinity transporter (Km in the mM
range), which is in accordance with the findings described in
previous reports (32, 59). The plasmid-encoded PTSLac also
has a low affinity for galactose. Indeed, in strains devoid of
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GalP, the galactose consumption rate slowed markedly at
concentrations of galactose in the medium of about 6 to 7
mM. The strain equipped with GalP (NZ9000) showed the
highest rate of galactose consumption, while the lowest was
observed in the strain mainly importing galactose via PTSLac
[NZ9000galPMK(pMG820)] (Fig. 4). The data pinpoint GalP
as the transporter displaying the highest capacity to take up
galactose. In summary, the GalP/Leloir pathway consumes ga-
lactose faster and is fully active with galactose at concentra-
tions down to about 1.5 mM. Given these properties, the GalP/
Leloir route appeared to be the best target for manipulations
aiming at enhanced galactose consumption in L. lactis. Over-
expression of the gal genes (galPMKT) in strain NZ9000 did
not lead to an enhanced galactose consumption rate. A con-
siderable increase in the maximal concentrations of the phos-
phorylated Leloir intermediates -Gal1P and -G1P pointed
to an obstruction at the level of -PGM. This result was not
completely unexpected, as we have recently shown that the
step catalyzed by -PGM is a major bottleneck in the utiliza-
tion of galactose (45). In line with this observation, the -PGM
step was also critical for the improvement of the galactose
uptake capacity in Saccharomyces cerevisiae (12). In the present
study, overproduction of a heterologous -PGM (from S. ther-
mophilus) alone or in combination with gal gene products,
namely, GalP or GalPMKT, resulted in higher galactose con-
sumption rates. The best performance, corresponding to a 50%
increase relative to wild-type levels, was obtained with the
NZ9000 strain that overexpressed the genes encoding GalP
and -PGM. However, the galactose consumption rate in this
engineered strain is 2-fold lower than the rate of glucose uti-
lization in strain NZ9000 (13). Although a full explanation
cannot be put forward at this stage, it would not be surprising
if regulatory events such as CcpA-mediated regulation of cat-
abolic genes are involved. CcpA-mediated activation of the las
operon (pfk, pyk, and ldh) is not in effect during growth on
galactose (40, 66), which could in part explain the decreased
glycolytic flux. In view of these findings, we postulate that
further improvement of galactose utilization may require en-
gineering of regulatory genes, such as ccpA or even specific
sugar regulators. Future approaches, combining increased ex-
pression of catabolic genes, namely, galactose permease and
-PGM, with engineering of the catabolite control network
could create L. lactis strains preferring galactose over glucose
and lactose, a desirable trait considering that the concentration
of lactose in milk fermentations is normally higher than that of
galactose (3). Thus, galactose scavengers would be ideal start-
ers in the manufacture of galactose-free dairy products.
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